BCL2 and breast cancer: LncRNA NONHSAT141924 was found to promote paclitaxel resistance by inhibiting the p-CREB/Bcl-2 apoptosis pathway, and overexpression of lncRNA NONHSAT141924 increases Bcl-2 and p-CREB protein levels in breast cancer [156].